Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 68461 to 2217 of 2217 entries
Sorted by: Best Match Show Resources per page
Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection.

Clinica chimica acta; international journal of clinical chemistry

Garg S, Kumar Singh V, Chandra Sonkar S, Kelkar H, Singh S, Garg S, Arya M, Husain F, Chandra L, Chitkara A, Talukdar T, Goswami B, Chandra Koner B.
PMID: 35007527
Clin Chim Acta. 2022 Jan 07; doi: 10.1016/j.cca.2022.01.003. Epub 2022 Jan 07.

BACKGROUND AND AIMS: Monoclonal/biclonalgammopathy of unknown significance (MGUS/BGUS) is observed in COVID-19. This study was conducted to determine the changes in serum protein electrophoresis (SPEP) in COVID-19.MATERIALS AND METHODS: In this descriptive (cross-sectional) study, serum inflammatory markers (CRP, IL-6...

Cite
Garg S, Kumar Singh V, Chandra Sonkar S, et al. Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection. Clin Chim Acta. 2022;doi: 10.1016/j.cca.2022.01.003.
Garg, S., Kumar Singh, V., Chandra Sonkar, S., Kelkar, H., Singh, S., Garg, S., Arya, M., Husain, F., Chandra, L., Chitkara, A., Talukdar, T., Goswami, B., & Chandra Koner, B. (2022). Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection. Clinica chimica acta; international journal of clinical chemistry, . https://doi.org/10.1016/j.cca.2022.01.003
Garg, Surbhi, et al. "Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection." Clinica chimica acta; international journal of clinical chemistry vol. (2022). doi: https://doi.org/10.1016/j.cca.2022.01.003
Garg S, Kumar Singh V, Chandra Sonkar S, Kelkar H, Singh S, Garg S, Arya M, Husain F, Chandra L, Chitkara A, Talukdar T, Goswami B, Chandra Koner B. Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection. Clin Chim Acta. 2022 Jan 07; doi: 10.1016/j.cca.2022.01.003. Epub 2022 Jan 07. PMID: 35007527; PMCID: PMC8739368.
Copy Download .nbib Format: NLM
Effect of direct-fed microbials on growth performance, blood biochemical indices, and immune status of female goats.

Animal biotechnology

Zhou A, Zhang X, Zhou Y, Xiao L, Li T.
PMID: 34904515
Anim Biotechnol. 2021 Dec 14;1-8. doi: 10.1080/10495398.2021.2014856. Epub 2021 Dec 14.

The effect of direct-feed microbial (DFM) treatment on body weight, serum biochemical indexes, serum immunoglobulins, and serum cytokines was studied. The study was a completely randomized design with 20 growing females Beichuan white goats, weighing 25.11 ± 1.96 kg,...

Cite
Zhou A, Zhang X, Zhou Y, et al. Effect of direct-fed microbials on growth performance, blood biochemical indices, and immune status of female goats. Anim Biotechnol. 2021;1-8doi: 10.1080/10495398.2021.2014856.
Zhou, A., Zhang, X., Zhou, Y., Xiao, L., & Li, T. (2021). Effect of direct-fed microbials on growth performance, blood biochemical indices, and immune status of female goats. Animal biotechnology, 1-8. https://doi.org/10.1080/10495398.2021.2014856
Zhou, Aimin, et al. "Effect of direct-fed microbials on growth performance, blood biochemical indices, and immune status of female goats." Animal biotechnology vol. (2021): 1-8. doi: https://doi.org/10.1080/10495398.2021.2014856
Zhou A, Zhang X, Zhou Y, Xiao L, Li T. Effect of direct-fed microbials on growth performance, blood biochemical indices, and immune status of female goats. Anim Biotechnol. 2021 Dec 14;1-8. doi: 10.1080/10495398.2021.2014856. Epub 2021 Dec 14. PMID: 34904515.
Copy Download .nbib Format: NLM
Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.

Journal of gynecology obstetrics and human reproduction

Maisonneuve E, Dugas A, Friszer S, Toly-Ndour C, Cariot L, Dhombres F, Cortey A, Mailloux A, Carbonne B, Jouannic JM.
PMID: 33741541
J Gynecol Obstet Hum Reprod. 2021 Sep;50(7):102119. doi: 10.1016/j.jogoh.2021.102119. Epub 2021 Mar 16.

BACKGROUND: Early intrauterine transfusion (IUT) is associated with a higher risk of fetal loss. Our objective was to evaluate the efficiciency of intravenous immunoglobulins (IVIG) to postpone the gestational age at first IUT beyond 20 weeks of gestation (WG)...

Cite
Maisonneuve E, Dugas A, Friszer S, et al. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study. J Gynecol Obstet Hum Reprod. 2021;50(7):102119doi: 10.1016/j.jogoh.2021.102119.
Maisonneuve, E., Dugas, A., Friszer, S., Toly-Ndour, C., Cariot, L., Dhombres, F., Cortey, A., Mailloux, A., Carbonne, B., & Jouannic, J. M. (2021). Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study. Journal of gynecology obstetrics and human reproduction, 50(7), 102119. https://doi.org/10.1016/j.jogoh.2021.102119
Maisonneuve, Emeline, et al. "Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study." Journal of gynecology obstetrics and human reproduction vol. 50,7 (2021): 102119. doi: https://doi.org/10.1016/j.jogoh.2021.102119
Maisonneuve E, Dugas A, Friszer S, Toly-Ndour C, Cariot L, Dhombres F, Cortey A, Mailloux A, Carbonne B, Jouannic JM. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study. J Gynecol Obstet Hum Reprod. 2021 Sep;50(7):102119. doi: 10.1016/j.jogoh.2021.102119. Epub 2021 Mar 16. PMID: 33741541.
Copy Download .nbib Format: NLM
Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes.

Journal of proteomics

Tan M, Ma J, Yang X, You Q, Guo X, Li Y, Wang R, Han G, Chen Y, Qiu X, Wang X, Zhang L.
PMID: 34890869
J Proteomics. 2021 Dec 07;252:104449. doi: 10.1016/j.jprot.2021.104449. Epub 2021 Dec 07.

B cells and immunoglobulins are implicated in the pathogenesis of chronic diseases, including coronary artery disease (CAD). However, it remains elusive how the humoral immunity is incriminated in the disease progression of CAD. Using serum samples of chronic coronary...

Cite
Tan M, Ma J, Yang X, et al. Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes. J Proteomics. 2021;252:104449doi: 10.1016/j.jprot.2021.104449.
Tan, M., Ma, J., Yang, X., You, Q., Guo, X., Li, Y., Wang, R., Han, G., Chen, Y., Qiu, X., Wang, X., & Zhang, L. (2021). Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes. Journal of proteomics, 252104449. https://doi.org/10.1016/j.jprot.2021.104449
Tan, Miaomiao, et al. "Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes." Journal of proteomics vol. 252 (2021): 104449. doi: https://doi.org/10.1016/j.jprot.2021.104449
Tan M, Ma J, Yang X, You Q, Guo X, Li Y, Wang R, Han G, Chen Y, Qiu X, Wang X, Zhang L. Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes. J Proteomics. 2021 Dec 07;252:104449. doi: 10.1016/j.jprot.2021.104449. Epub 2021 Dec 07. PMID: 34890869.
Copy Download .nbib Format: NLM
Cytokinergic IgE Action in Mast Cell Activation.

Frontiers in immunology

Bax HJ, Keeble AH, Gould HJ.
PMID: 22888332
Front Immunol. 2012 Aug 06;3:229. doi: 10.3389/fimmu.2012.00229. eCollection 2012.

Some 10 years ago it emerged that at sufficiently high concentrations certain monoclonal mouse IgEs exert previously unsuspected effects on mast cells. Thus they can both promote survival and induce activation of mast cells without the requirement for antigens....

Cite
Bax HJ, Keeble AH, Gould HJ. Cytokinergic IgE Action in Mast Cell Activation. Front Immunol. 2012;3:229doi: 10.3389/fimmu.2012.00229.
Bax, H. J., Keeble, A. H., & Gould, H. J. (2012). Cytokinergic IgE Action in Mast Cell Activation. Frontiers in immunology, 3229. https://doi.org/10.3389/fimmu.2012.00229
Bax, Heather J, et al. "Cytokinergic IgE Action in Mast Cell Activation." Frontiers in immunology vol. 3 (2012): 229. doi: https://doi.org/10.3389/fimmu.2012.00229
Bax HJ, Keeble AH, Gould HJ. Cytokinergic IgE Action in Mast Cell Activation. Front Immunol. 2012 Aug 06;3:229. doi: 10.3389/fimmu.2012.00229. eCollection 2012. PMID: 22888332; PMCID: PMC3412263.
Copy Download .nbib Format: NLM
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.

Cell reports

Lozano-Rodríguez R, Valentín-Quiroga J, Avendaño-Ortiz J, Martín-Quirós A, Pascual-Iglesias A, Terrón-Arcos V, Montalbán-Hernández K, Casalvilla-Dueñas JC, Bergón-Gutiérrez M, Alcamí J, García-Pérez J, Cascajero A, García-Garrido MÁ, Balzo-Castillo ÁD, Peinado M, Gómez L, Llorente-Fernández I, Martín-Miguel G, Herrero-Benito C, Benito JM, Rallón N, Vela-Olmo C, López-Morejón L, Cubillos-Zapata C, Aguirre LA, Fresno CD, López-Collazo E.
PMID: 34986327
Cell Rep. 2022 Jan 11;38(2):110235. doi: 10.1016/j.celrep.2021.110235. Epub 2021 Dec 21.

We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination. Plasma spike (S)-specific immunoglobulins peak after one vaccine shot...

Cite
Lozano-Rodríguez R, Valentín-Quiroga J, Avendaño-Ortiz J, et al. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell Rep. 2021;38(2):110235doi: 10.1016/j.celrep.2021.110235.
Lozano-Rodríguez, R., Valentín-Quiroga, J., Avendaño-Ortiz, J., Martín-Quirós, A., Pascual-Iglesias, A., Terrón-Arcos, V., Montalbán-Hernández, K., Casalvilla-Dueñas, J. C., Bergón-Gutiérrez, M., Alcamí, J., García-Pérez, J., Cascajero, A., García-Garrido, M. �. �., Balzo-Castillo, �. �. D., Peinado, M., Gómez, L., Llorente-Fernández, I., Martín-Miguel, G., Herrero-Benito, C., Benito, J. M., Rallón, N., Vela-Olmo, C., López-Morejón, L., Cubillos-Zapata, C., Aguirre, L. A., Fresno, C. D., & López-Collazo, E. (2022). Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell reports, 38(2), 110235. https://doi.org/10.1016/j.celrep.2021.110235
Lozano-Rodríguez, Roberto, et al. "Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19." Cell reports vol. 38,2 (2022): 110235. doi: https://doi.org/10.1016/j.celrep.2021.110235
Lozano-Rodríguez R, Valentín-Quiroga J, Avendaño-Ortiz J, Martín-Quirós A, Pascual-Iglesias A, Terrón-Arcos V, Montalbán-Hernández K, Casalvilla-Dueñas JC, Bergón-Gutiérrez M, Alcamí J, García-Pérez J, Cascajero A, García-Garrido MÁ, Balzo-Castillo ÁD, Peinado M, Gómez L, Llorente-Fernández I, Martín-Miguel G, Herrero-Benito C, Benito JM, Rallón N, Vela-Olmo C, López-Morejón L, Cubillos-Zapata C, Aguirre LA, Fresno CD, López-Collazo E. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell Rep. 2022 Jan 11;38(2):110235. doi: 10.1016/j.celrep.2021.110235. Epub 2021 Dec 21. PMID: 34986327; PMCID: PMC8687760.
Copy Download .nbib Format: NLM
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis.

Multiple sclerosis and related disorders

Spiezia AL, Cerbone V, Molinari EA, Capasso N, Lanzillo R, Carotenuto A, Petracca M, Novarella F, Covelli B, Scalia G, Brescia Morra V, Moccia M.
PMID: 34871857
Mult Scler Relat Disord. 2021 Nov 29;57:103431. doi: 10.1016/j.msard.2021.103431. Epub 2021 Nov 29.

No abstract available.

Cite
Spiezia AL, Cerbone V, Molinari EA, et al. Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis. Mult Scler Relat Disord. 2021;57:103431doi: 10.1016/j.msard.2021.103431.
Spiezia, A. L., Cerbone, V., Molinari, E. A., Capasso, N., Lanzillo, R., Carotenuto, A., Petracca, M., Novarella, F., Covelli, B., Scalia, G., Brescia Morra, V., & Moccia, M. (2021). Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis. Multiple sclerosis and related disorders, 57103431. https://doi.org/10.1016/j.msard.2021.103431
Spiezia, Antonio Luca, et al. "Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103431. doi: https://doi.org/10.1016/j.msard.2021.103431
Spiezia AL, Cerbone V, Molinari EA, Capasso N, Lanzillo R, Carotenuto A, Petracca M, Novarella F, Covelli B, Scalia G, Brescia Morra V, Moccia M. Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 29;57:103431. doi: 10.1016/j.msard.2021.103431. Epub 2021 Nov 29. PMID: 34871857.
Copy Download .nbib Format: NLM
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.

iScience

Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S.
PMID: 34430803
iScience. 2021 Sep 24;24(9):103006. doi: 10.1016/j.isci.2021.103006. Epub 2021 Aug 20.

Hyperimmune immunoglobulin (hCoV-2IG) generated from SARS-CoV-2 convalescent plasma (CP) are under evaluation in clinical trials. Here we explored the antibody epitope repertoire, and virus neutralizing capacity of six hCoV-2IG batches as well as nine CP against SARS-CoV-2 and emerging...

Cite
Tang J, Lee Y, Ravichandran S, et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience. 2021;24(9):103006doi: 10.1016/j.isci.2021.103006.
Tang, J., Lee, Y., Ravichandran, S., Grubbs, G., Huang, C., Stauft, C. B., Wang, T., Golding, B., Golding, H., & Khurana, S. (2021). Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience, 24(9), 103006. https://doi.org/10.1016/j.isci.2021.103006
Tang, Juanjie, et al. "Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern." iScience vol. 24,9 (2021): 103006. doi: https://doi.org/10.1016/j.isci.2021.103006
Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience. 2021 Sep 24;24(9):103006. doi: 10.1016/j.isci.2021.103006. Epub 2021 Aug 20. PMID: 34430803; PMCID: PMC8378063.
Copy Download .nbib Format: NLM
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.

Journal of cutaneous medicine and surgery

Kofler K, Strölin A, Geiger V, Kofler L.
PMID: 33779349
J Cutan Med Surg. 2021 Sep;25(5):504-510. doi: 10.1177/12034754211003525. Epub 2021 Mar 28.

BACKGROUND: Livedoid vasculopathy (LV) is a rare disease characterized by livedo racemosa, atrophie blanche, ulcerations, and severe pain. Low molecular weight heparins and rivaroxaban can be used in LV-patients. In addition, intravenous immunoglobulins (IVIG) have been described as treatment-option.OBJECTIVES:...

Cite
Kofler K, Strölin A, Geiger V, et al. Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level. J Cutan Med Surg. 2021;25(5):504-510doi: 10.1177/12034754211003525.
Kofler, K., Strölin, A., Geiger, V., & Kofler, L. (2021). Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level. Journal of cutaneous medicine and surgery, 25(5), 504-510. https://doi.org/10.1177/12034754211003525
Kofler, Katrin, et al. "Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level." Journal of cutaneous medicine and surgery vol. 25,5 (2021): 504-510. doi: https://doi.org/10.1177/12034754211003525
Kofler K, Strölin A, Geiger V, Kofler L. Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level. J Cutan Med Surg. 2021 Sep;25(5):504-510. doi: 10.1177/12034754211003525. Epub 2021 Mar 28. PMID: 33779349; PMCID: PMC8474298.
Copy Download .nbib Format: NLM
Showing 68461 to 2217 of 2217 entries